“The safety of iptacopan was evaluated in a comprehensive nonclinical program consisting of good laboratory practice compliant toxicology studies in rats and dogs (most sensitive species), a short study in monkeys, reproductive toxicology studies in rats and rabbits, and carcinogenicity assessments in rats and transgenic mice.”
Rats and dogs considered the most sensitive species
“The safety of iptacopan was evaluated in a comprehensive nonclinical program consisting of good laboratory practice compliant toxicology studies in rats and dogs (most sensitive species), a short study in monkeys, reproductive toxicology studies in rats and rabbits, and carcinogenicity assessments in rats and transgenic mice.”
“Iptacopan administered at the high-dose (~10 times the clinical exposure at the maximum recommended human dose [MRHD], based on plasma area under the concentration-time curve [AUC]) resulted in decreased leukocyte parameters in male dogs at the end of the recovery period.”
Rat and dog (most sensitive species); short study in monkeys
“The safety of iptacopan was evaluated in a comprehensive nonclinical program consisting of good laboratory practice compliant toxicology studies in rats and dogs (most sensitive species), a short study in monkeys, reproductive toxicology studies in rats and rabbits, and carcinogenicity assessments in rats and transgenic mice.”
“The safety of iptacopan was evaluated in a comprehensive nonclinical program consisting of good laboratory practice compliant toxicology studies in rats and dogs (most sensitive species), a short study in monkeys, reproductive toxicology studies in rats and rabbits, and carcinogenicity assessments in rats and transgenic mice.”
“Carcinogenicity studies conducted with oral administration of iptacopan in RasH2 transgenic mice with doses up to 1,000 mg/kg/day for 6 months and in rats with doses up to 750 mg/kg/day for 2 years did not identify any carcinogenic potential.”
No surrogate used; iptacopan inhibits the alternative pathway in rat, dog and rabbit serum
“Zymosan-induced MAC deposition assays exhibited IC50 of ~100nM in serum of mouse, rabbit, pig, and human (in serum and whole blood), and ~500nM in serum of rat and dog.”